This study—making use of TCGA and GEO data for differential gene expression, on the basis of AXL mRNA expression levels found in normal compared to cholangiocarcinoma patients—identified AXL as an essential factor regulating tumor progression in bile duct cancer-affected patients with metastasis and poor prognosis [26,27]. This evidence concerns the gene AXL and bile duct cancer.